Hypercholesterolemia Treatment Market, Global Outlook and Forecast 2023-2029

Report ID: MMG251411 | Category: Medical Care | Pages: 66 | Format: PDF | Published Date: October 26,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. Presence of low-density Lipoprotein Cholesterol (LDL-C) or bad cholesterol in the blood, may lead to cardiovascular diseases. Hypercholesterolemia is caused due to a combination of genetic and environmental factors. Environmental factors include excessive diet intake and obesity.  In case of genetic factors, the number of copies of the gene determines the severity of the disease. People with the homozygous form (two copies of the gene) generally suffer from severe cardiovascular diseases during childhood, while those with the heterozygous form (with a single copy of the gene) suffer from heart diseases in their 30s or 40s.
This report aims to provide a comprehensive presentation of the global market for Hypercholesterolemia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypercholesterolemia Treatment. This report contains market size and forecasts of Hypercholesterolemia Treatment in global, including the following market information:
Global Hypercholesterolemia Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hypercholesterolemia Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
AEM-2802 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hypercholesterolemia Treatment include CymaBay Therapeutics Inc, Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc, Regeneron Pharmaceuticals Inc, RegenxBio Inc and The Medicines Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypercholesterolemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypercholesterolemia Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hypercholesterolemia Treatment Market Segment Percentages, by Type, 2022 (%)
    AEM-2802
    AEM-2814
    Alirocumab
    Evinacumab
    Others
Global Hypercholesterolemia Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hypercholesterolemia Treatment Market Segment Percentages, by Application, 2022 (%)
    Clinic
    Hospital
    Others
Global Hypercholesterolemia Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hypercholesterolemia Treatment Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypercholesterolemia Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hypercholesterolemia Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    CymaBay Therapeutics Inc
    Daewoong Co Ltd
    Gemphire Therapeutics Inc
    LipimetiX Development Inc
    Regeneron Pharmaceuticals Inc
    RegenxBio Inc
    The Medicines Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hypercholesterolemia Treatment, market overview.
Chapter 2: Global Hypercholesterolemia Treatment market size in revenue.
Chapter 3: Detailed analysis of Hypercholesterolemia Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hypercholesterolemia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Hypercholesterolemia Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Hypercholesterolemia Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hypercholesterolemia Treatment Overall Market Size
    2.1 Global Hypercholesterolemia Treatment Market Size: 2022 VS 2029
    2.2 Global Hypercholesterolemia Treatment Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Hypercholesterolemia Treatment Players in Global Market
    3.2 Top Global Hypercholesterolemia Treatment Companies Ranked by Revenue
    3.3 Global Hypercholesterolemia Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Hypercholesterolemia Treatment Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Hypercholesterolemia Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Hypercholesterolemia Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Hypercholesterolemia Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Hypercholesterolemia Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Hypercholesterolemia Treatment Market Size Markets, 2022 & 2029
        4.1.2 AEM-2802
        4.1.3 AEM-2814
        4.1.4 Alirocumab
        4.1.5 Evinacumab
        4.1.6 Others
    4.2 By Type - Global Hypercholesterolemia Treatment Revenue & Forecasts
        4.2.1 By Type - Global Hypercholesterolemia Treatment Revenue, 2018-2023
        4.2.2 By Type - Global Hypercholesterolemia Treatment Revenue, 2024-2029
        4.2.3 By Type - Global Hypercholesterolemia Treatment Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Hypercholesterolemia Treatment Market Size, 2022 & 2029
        5.1.2 Clinic
        5.1.3 Hospital
        5.1.4 Others
    5.2 By Application - Global Hypercholesterolemia Treatment Revenue & Forecasts
        5.2.1 By Application - Global Hypercholesterolemia Treatment Revenue, 2018-2023
        5.2.2 By Application - Global Hypercholesterolemia Treatment Revenue, 2024-2029
        5.2.3 By Application - Global Hypercholesterolemia Treatment Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Hypercholesterolemia Treatment Market Size, 2022 & 2029
    6.2 By Region - Global Hypercholesterolemia Treatment Revenue & Forecasts
        6.2.1 By Region - Global Hypercholesterolemia Treatment Revenue, 2018-2023
        6.2.2 By Region - Global Hypercholesterolemia Treatment Revenue, 2024-2029
        6.2.3 By Region - Global Hypercholesterolemia Treatment Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Hypercholesterolemia Treatment Revenue, 2018-2029
        6.3.2 US Hypercholesterolemia Treatment Market Size, 2018-2029
        6.3.3 Canada Hypercholesterolemia Treatment Market Size, 2018-2029
        6.3.4 Mexico Hypercholesterolemia Treatment Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Hypercholesterolemia Treatment Revenue, 2018-2029
        6.4.2 Germany Hypercholesterolemia Treatment Market Size, 2018-2029
        6.4.3 France Hypercholesterolemia Treatment Market Size, 2018-2029
        6.4.4 U.K. Hypercholesterolemia Treatment Market Size, 2018-2029
        6.4.5 Italy Hypercholesterolemia Treatment Market Size, 2018-2029
        6.4.6 Russia Hypercholesterolemia Treatment Market Size, 2018-2029
        6.4.7 Nordic Countries Hypercholesterolemia Treatment Market Size, 2018-2029
        6.4.8 Benelux Hypercholesterolemia Treatment Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Hypercholesterolemia Treatment Revenue, 2018-2029
        6.5.2 China Hypercholesterolemia Treatment Market Size, 2018-2029
        6.5.3 Japan Hypercholesterolemia Treatment Market Size, 2018-2029
        6.5.4 South Korea Hypercholesterolemia Treatment Market Size, 2018-2029
        6.5.5 Southeast Asia Hypercholesterolemia Treatment Market Size, 2018-2029
        6.5.6 India Hypercholesterolemia Treatment Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Hypercholesterolemia Treatment Revenue, 2018-2029
        6.6.2 Brazil Hypercholesterolemia Treatment Market Size, 2018-2029
        6.6.3 Argentina Hypercholesterolemia Treatment Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Hypercholesterolemia Treatment Revenue, 2018-2029
        6.7.2 Turkey Hypercholesterolemia Treatment Market Size, 2018-2029
        6.7.3 Israel Hypercholesterolemia Treatment Market Size, 2018-2029
        6.7.4 Saudi Arabia Hypercholesterolemia Treatment Market Size, 2018-2029
        6.7.5 UAE Hypercholesterolemia Treatment Market Size, 2018-2029
7 Hypercholesterolemia Treatment Companies Profiles
    7.1 CymaBay Therapeutics Inc
        7.1.1 CymaBay Therapeutics Inc Company Summary
        7.1.2 CymaBay Therapeutics Inc Business Overview
        7.1.3 CymaBay Therapeutics Inc Hypercholesterolemia Treatment Major Product Offerings
        7.1.4 CymaBay Therapeutics Inc Hypercholesterolemia Treatment Revenue in Global Market (2018-2023)
        7.1.5 CymaBay Therapeutics Inc Key News & Latest Developments
    7.2 Daewoong Co Ltd
        7.2.1 Daewoong Co Ltd Company Summary
        7.2.2 Daewoong Co Ltd Business Overview
        7.2.3 Daewoong Co Ltd Hypercholesterolemia Treatment Major Product Offerings
        7.2.4 Daewoong Co Ltd Hypercholesterolemia Treatment Revenue in Global Market (2018-2023)
        7.2.5 Daewoong Co Ltd Key News & Latest Developments
    7.3 Gemphire Therapeutics Inc
        7.3.1 Gemphire Therapeutics Inc Company Summary
        7.3.2 Gemphire Therapeutics Inc Business Overview
        7.3.3 Gemphire Therapeutics Inc Hypercholesterolemia Treatment Major Product Offerings
        7.3.4 Gemphire Therapeutics Inc Hypercholesterolemia Treatment Revenue in Global Market (2018-2023)
        7.3.5 Gemphire Therapeutics Inc Key News & Latest Developments
    7.4 LipimetiX Development Inc
        7.4.1 LipimetiX Development Inc Company Summary
        7.4.2 LipimetiX Development Inc Business Overview
        7.4.3 LipimetiX Development Inc Hypercholesterolemia Treatment Major Product Offerings
        7.4.4 LipimetiX Development Inc Hypercholesterolemia Treatment Revenue in Global Market (2018-2023)
        7.4.5 LipimetiX Development Inc Key News & Latest Developments
    7.5 Regeneron Pharmaceuticals Inc
        7.5.1 Regeneron Pharmaceuticals Inc Company Summary
        7.5.2 Regeneron Pharmaceuticals Inc Business Overview
        7.5.3 Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Major Product Offerings
        7.5.4 Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Revenue in Global Market (2018-2023)
        7.5.5 Regeneron Pharmaceuticals Inc Key News & Latest Developments
    7.6 RegenxBio Inc
        7.6.1 RegenxBio Inc Company Summary
        7.6.2 RegenxBio Inc Business Overview
        7.6.3 RegenxBio Inc Hypercholesterolemia Treatment Major Product Offerings
        7.6.4 RegenxBio Inc Hypercholesterolemia Treatment Revenue in Global Market (2018-2023)
        7.6.5 RegenxBio Inc Key News & Latest Developments
    7.7 The Medicines Company
        7.7.1 The Medicines Company Company Summary
        7.7.2 The Medicines Company Business Overview
        7.7.3 The Medicines Company Hypercholesterolemia Treatment Major Product Offerings
        7.7.4 The Medicines Company Hypercholesterolemia Treatment Revenue in Global Market (2018-2023)
        7.7.5 The Medicines Company Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Hypercholesterolemia Treatment Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?